PreciseDx Company

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

Last Funding Date: 2022-01-11
Investors Number: 4.0
Industry: Medical BioTech
Last Funding Type: Series A
Headquarters: New York, New York, United States
Total Funding: 10750000.0
Funding Status: Early Stage Venture
Employee Number: 45200
Technology: ['BioTech & HealthTech']
Estimated Revenue: $1M to $10M
Founded Date: 2019-01-01